APC/FireTM 750 anti-mouse/human CD44 [IM7] and 4 more items

BioLegend Inc. has been awarded contract A207_PO-0445156 by the University of Virginia for the provision of specialized flow cytometry reagents. The contract, valued at $1,761.20, was awarded on June 4, 2026, and encompasses the delivery of five distinct monoclonal antibody products to Rahul Sharma at the University of Virginia in Virginia. The reagents include APC/FireTM 750 anti-mouse/human CD44 [IM7], FITC anti-human CD16 [B73.1], APC/Cyanine7 anti-human CD4 [OKT4], Brilliant Violet 510TM anti-human IL-4 [MP4-25D2], and PerCP/Cyanine5.5 anti-human CD8a [RPA-T8], with quantities ranging from one to two units per line item.

The contract deliverables consist of fluorescently-labeled antibodies used in immunological research and diagnostic applications. These reagents target specific human immune cell surface markers and intracellular cytokines, supporting flow cytometric analysis of T cell populations, cellular differentiation, and immune function assessment. Unit prices for individual products range from $133.00 to $309.75, reflecting the specialized nature of the conjugated monoclonal antibodies procured under this agreement.